Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Healthcare Triangle (HCTI) Net Income towards Common Stockholders (2020 - 2025)

Healthcare Triangle's Net Income towards Common Stockholders history spans 6 years, with the latest figure at $1.9 million for Q3 2025.

  • For Q3 2025, Net Income towards Common Stockholders rose 52.6% year-over-year to $1.9 million; the TTM value through Sep 2025 reached -$2.5 million, up 33.98%, while the annual FY2024 figure was -$6.0 million, 31.28% up from the prior year.
  • Net Income towards Common Stockholders for Q3 2025 was $1.9 million at Healthcare Triangle, up from -$1.4 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $1.9 million in Q3 2025 and bottomed at -$4.9 million in Q4 2022.
  • The 5-year median for Net Income towards Common Stockholders is -$1.7 million (2025), against an average of -$1.5 million.
  • The largest annual shift saw Net Income towards Common Stockholders plummeted 1535.08% in 2021 before it soared 164.28% in 2024.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$3.4 million in 2021, then crashed by 40.91% to -$4.9 million in 2022, then skyrocketed by 65.42% to -$1.7 million in 2023, then increased by 19.71% to -$1.3 million in 2024, then soared by 241.39% to $1.9 million in 2025.
  • Per Business Quant, the three most recent readings for HCTI's Net Income towards Common Stockholders are $1.9 million (Q3 2025), -$1.4 million (Q2 2025), and -$1.7 million (Q1 2025).